Interim versus standard methadone treatment: a benefit-cost analysis

Area of Science:

• Addiction Medicine
• Health Economics
• Clinical Trials

Background:

• Methadone maintenance treatment is a standard for opioid use disorder.
• The role of counseling intensity alongside methadone requires further economic evaluation.
• Interim methadone (IM) offers a less intensive, potentially more accessible, treatment option.

Purpose of the Study:

• To conduct a benefit-cost analysis of interim methadone (IM) versus standard methadone treatment with counseling.
• To evaluate the economic impact of different methadone treatment durations and counseling intensities.

Main Methods:

• A randomized clinical trial involving 200 newly-admitted methadone patients.
• Comparison of interim methadone (4 months) against 12 months of methadone with counseling.
• Data collection included health, residential treatment, criminal justice costs, and income at baseline and 4- and 12-month follow-ups.
• Benefit-cost analysis performed using 2010 dollars.

Main Results:

• The interim methadone condition demonstrated higher net benefits.
• After controlling for baseline variables, the difference in net monetary benefits between IM and counseling was not statistically significant.
• The combined sample showed a non-significant pre- to post-treatment net benefit of $1470 and a benefit-cost ratio of 1.5 with conservative benefit calculation.

Conclusions:

• While interim methadone may offer greater net benefits, the economic advantage over standard counseling is not statistically significant in this trial.
• The findings suggest that less intensive methadone treatment models warrant further economic investigation.
• Benefit-cost analyses in addiction treatment require careful consideration of benefit valuation methods.